Skip to main content
# Title Department Research Year
61 New 1, 3, 4‐oxadiazoles linked with the 1, 2, 3‐triazole moiety as antiproliferative agents targeting the EGFR tyrosine kinase Department of Pharmaceutical Organic Chemistry 2022
62 Development and validation of a novel evaporation setup-assisted TLC method with fluorescence detection for determination of flibanserin in pharmaceutical and biological samples Department of Pharmaceutical Analytical Chemistry 2022
63 Double-signal quantification of amoxicillin based on interaction with 4-aminoantipyrine at copper and nitrogen co-doped carbon quantum dots as an artificial nanozyme Department of Pharmaceutical Analytical Chemistry 2022
64 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022
65 Development of magnetic molecularly imprinted polymers for the extraction of salivary pepsin prior to analysis by a novel HPLC-SEC method Department of Pharmaceutical Analytical Chemistry 2022
66 Tailoring of novel azithromycin loaded zinc oxide nanoparticles for wound healing Department of Microbiology and Immunology 2022
67 Discovery of new pyrimido [5, 4-c] quinolines as potential antiproliferative agents with multitarget actions: Rapid synthesis, docking, and ADME studies Department of Pharmaceutical Organic Chemistry 2022
68 New 1,3,4-Oxadiazole-Chalcone/Benzimidazole Hybrids as Potent Anti-proliferative Agents Department of Pharmaceutical Organic Chemistry 2022
69 EVALUATION OF RHEUM PALMATUM RHIZOMES AVAILABLE IN JORDANIAN MARKETS AND INVESTIGATION OF ITS POTENTIAL USE AS HAIR DYE COSMETICS 2022
70 Long term high fat diet induces metabolic disorders and aggravates behavioral disorders and cognitive deficits in MAPT P301L transgenic mice Department of Pharmacology 2022